Federal regulators cleared a novel therapeutic agent on Wednesday intended to improve survival prospects for patients battling advanced pancreatic cancer...
drug approval
Federal regulators granted approval Wednesday to Rasonque, a new oral medication designed to treat advanced pancreatic cancer. The drug, developed...